Drawing for EUROFINS TESTING FOR A BETTER WORLD

USPTO serial 79218147

EUROFINS TESTING FOR A BETTER WORLD

Reviewed by CopyMark Law Group

Reg. 5588463Status 709
Filing date
Status date
Registration date
Oct 23, 2018
Examiner
SERVANCE, RENEE L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EUROFINS TESTING FOR A BETTER WORLD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JOSEPH SOFER, ESQ.

JOSEPH SOFER, ESQ. IPSILON USA215 LEXINGTON AVE1301NEW YORK, NY 10016

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations for scientific purposes not for medical use; diagnostic preparations for scientific use; molecular tools, namely, reagents such as probes, reaction primers and test fractions for analysis and diagnosis, all for scientific use; molecular preparations, namely, biochemical reagents, namely, probes, reaction primers and test fractions for analysis and diagnosis, all for scientific use; analytical and diagnostic testing preparations for scientific and research use, including reagents and buffers; chemical compounds for scientific use and in the field of research, and not for medical use, in particular oligonucleotides, poly-nucleotides, synthetic genes; oligonucleotide sequences for DNA micro-arrays for scientific purposes; genetic engineering chemicals, namely, genes, gene fragments and combinations thereof for scientific purposesSECTION 71 - CANCELLED—
005Diagnostic preparations for medical and veterinary use; chemical analysis reagents for medical and veterinary use; biological reagents for medical and veterinary use; diagnostic reagents for medical and veterinary use; chemical reagents for medical and veterinary use; oligonucleotides for medical and veterinary use; poly-nucleotides, and synthetic genes for medical and veterinary use; genetic engineering chemicals, namely, genes, gene fragments and combinations thereof for medical purposesSECTION 71 - CANCELLED—
009Apparatus for diagnosis, measurement and analysis, not for medical use, namely, spectroscopy instruments, namely, readers for ELISA, namely, microplate readers, test strip readers and tube readers; laboratory equipment, namely, photometers; software for the establishment, systematization, evaluation and/or collection of analytical and diagnostics dataSECTION 71 - CANCELLED—
035Personnel placement services, namely, provision of specialized personnel for scientific analysis in the fields of research and development, in the fields of chemical analysis, physico-chemical, biochemistry, molecular biology, virology, and cell biologySECTION 71 - CANCELLED—
042Research and development in the fields of animal and plant biology, physico-chemical and microbiology; research services, namely, performing physical, chemical, physico-chemical, biochemical, biological and microbiological analyzes in the fields of plant and animal products; research services, namely, carrying out physical, chemical, physico-chemical, biochemical, biological or microbiological analyzes in the food, chemical, pharmaceutical, cosmetic and environmental industries; research services, namely, performing genetic analyzes in the fields of plant and animal products; research services, namely, carrying out genetic analyzes in the food, chemical, pharmaceutical, cosmetic and environmental industries; research services, namely, nuclear magnetic resonance analyzes in the food, chemical, pharmaceutical, cosmetic and environmental industries; development of new technology for others, namely, method development services, namely, establishing and maintaining chemical, biological, biomolecular test methods; conducting scientific projects feasibility studies; professional consulting in the field of scientific researchSECTION 71 - CANCELLED—
044Medical services, namely, blood testing, saliva testing and body fluid testing; medical services, namely, serological and urinary testing services; medical testing services in the field of genetics, namely, birth defects and prenatal testing; DNA screening for medical purposes; medical and health services related to DNA, namely, genetic testing for medical uses; hospital services; medical services and medical services in the field of genetics; medical clinic services; medical consultancy services; genetic counseling; medical equipment rental; maintaining personal medical history records and files online; human fertility treatment services; hygiene and beauty care for human beings and animals; collection and preservation of human blood; medical testing for diagnostic purposes; information relating to cardiovascular health and cardiovascular health analysis; medical services, namely, a program to improve health and quality of life in the field of cardiovascular diseases, namely, medical monitoring and reporting in the field of cardiovascular diseases; medical diagnostic tests in the field of diabetesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 10, 2026INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Aug 15, 2026XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Aug 15, 2026XXCRGENERIC MADRID TRANSACTION CREATED—
Jul 23, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 9, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 9, 2025C71TCANCELLED SECTION 71—
Apr 12, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 5, 2019XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Feb 5, 2019XXCRGENERIC MADRID TRANSACTION CREATED—
Jan 23, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 23, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 7, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 4, 2018GPNXNOTIFICATION PROCESSED BY IB—
Jul 18, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 18, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 18, 2018NPUBNOTICE OF PUBLICATION—
Jul 5, 2018CNEAEXAMINERS AMENDMENT MAILED—
Jul 3, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 3, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Jul 3, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 21, 2018CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 20, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 15, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 15, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 11, 2018ALIEASSIGNED TO LIE—
May 7, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 25, 2018DOCKASSIGNED TO EXAMINER—
Nov 24, 2017RFNTREFUSAL PROCESSED BY IB—
Nov 6, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 6, 2017RFRRREFUSAL PROCESSED BY MPU—
Oct 31, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 30, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 20, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 16, 2017DOCKASSIGNED TO EXAMINER—
Oct 16, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 12, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance